[ { "interactionId": 8951, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 3784, "ligandName": "[125I]GLP-1-(7-37) (human)", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "", "affinityParameter": "", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ ] }, { "interactionId": 2879, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 1137, "ligandName": "[125I]exendin-(9-39)", "ligandContext": "", "endogenous": false, "type": "Antagonist", "action": "Antagonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.3", "affinityParameter": "pKd", "originalAffinity": "5x10-9", "originalAffinityType": "Kd", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 2875, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 1133, "ligandName": "liraglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.2", "affinityParameter": "pEC50", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3586, "pmid": 10794683, "type": "Journal", "title": "J Med Chem", "year": 2000, "volume": "43", "issue": "9", "pages": "1664-9", "articleTitle": "Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.", "authors": "Knudsen LB, Nielsen PF, Huusfeldt PO, Johansen NL, Madsen K, Pedersen FZ, Thøgersen H, Wilken M, Agersø H" } ] }, { "interactionId": 79370, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 7387, "ligandName": "lixisenatide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.9", "affinityParameter": "pKi", "originalAffinity": "1.33x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "CHO-K1 cells overexpressing the human GLP-1 receptor.", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 24217, "pmid": 20570597, "type": "Journal", "title": "Regul Pept", "year": 2010, "volume": "164", "issue": "2-3", "pages": "58-64", "articleTitle": "Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes.", "authors": "Werner U, Haschke G, Herling AW, Kramer W", "pubStatus": "" } ] }, { "interactionId": 82315, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 8544, "ligandName": "WB4-24", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "4.9", "affinityParameter": "pA2", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 28503, "pmid": 25176008, "type": "Journal", "title": "Br J Pharmacol", "year": 2015, "volume": "172", "issue": "1", "pages": "64-79", "articleTitle": "The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia.", "authors": "Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW, Wang YX", "pubStatus": "" } ] }, { "interactionId": 84391, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 9588, "ligandName": "Peptide 5 [PMID: 28562585]", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.5", "affinityParameter": "pKi", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 33205, "pmid": 28562585, "type": "Journal", "title": "Nature", "year": 2017, "volume": "546", "issue": "7657", "pages": "254-258", "articleTitle": "Crystal structure of the GLP-1 receptor bound to a peptide agonist.", "authors": "Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A et al." } ] }, { "interactionId": 84392, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 9588, "ligandName": "Peptide 5 [PMID: 28562585]", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.8", "affinityParameter": "pEC50", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 33205, "pmid": 28562585, "type": "Journal", "title": "Nature", "year": 2017, "volume": "546", "issue": "7657", "pages": "254-258", "articleTitle": "Crystal structure of the GLP-1 receptor bound to a peptide agonist.", "authors": "Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A et al." } ] }, { "interactionId": 2877, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 1135, "ligandName": "exendin-4", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "8.7 - 9.0", "affinityParameter": "pKi", "originalAffinity": "1.99x10-9 - 1x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 87850, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 11429, "ligandName": "tirzepatide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.4", "affinityParameter": "pKi", "originalAffinity": "4.23x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 41453, "pmid": 30473097, "type": "Journal", "title": "Mol Metab", "year": 2018, "volume": "18", "issue": "", "pages": "3-14", "articleTitle": "LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.", "authors": "Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 2876, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 1134, "ligandName": "[125I]GLP-1-(7-36)-amide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "9.3", "affinityParameter": "pKd", "originalAffinity": "5x10-10", "originalAffinityType": "Kd", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 88592, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 11927, "ligandName": "LSN3318839", "ligandContext": "", "endogenous": false, "type": "Allosteric modulator", "action": "Positive", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.8", "affinityParameter": "pEC50", "originalAffinity": "1.4x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 43503, "pmid": 33721487, "type": "Journal", "title": "J Med Chem", "year": 2021, "volume": "64", "issue": "6", "pages": "3439-3448", "articleTitle": "Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 Receptor.", "authors": "Willard FS, Wainscott DB, Showalter AD, Stutsman C, Ma W, Cardona GR, Zink RW, Corkins CM, Chen Q, Yumibe N et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 88771, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 12064, "ligandName": "danuglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "6.4", "affinityParameter": "pKi", "originalAffinity": "3.6x10-7", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "Binding affinity of danuglipron evaluated in a competition binding assay with radiolabeled GLP-1 as tracer", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 43828, "pmid": 35647711, "type": "Journal", "title": "J Med Chem", "year": 2022, "volume": "65", "issue": "12", "pages": "8208-8226", "articleTitle": "A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor.", "authors": "Griffith DA, Edmonds DJ, Fortin JP, Kalgutkar AS, Kuzmiski JB, Loria PM, Saxena AR, Bagley SW, Buckeridge C, Curto JM et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 8217, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 884, "ligandName": "T-0632", "ligandContext": "", "endogenous": false, "type": "Antagonist", "action": "Antagonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "4.7", "affinityParameter": "pIC50", "originalAffinity": "2.1x10-5", "originalAffinityType": "IC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 14694, "pmid": 11498540, "type": "Journal", "title": "J Biol Chem", "year": 2001, "volume": "276", "issue": "41", "pages": "37787-93", "articleTitle": "A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.", "authors": "Tibaduiza EC, Chen C, Beinborn M" } ] }, { "interactionId": 2878, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "ligandId": 1136, "ligandName": "glucagon", "endogenous": true, "type": "Agonist", "action": "Full agonist", "concentrationRange": "", "affinity": "6.9 - 7.0", "affinityParameter": "pKi", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 2874, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 1132, "ligandName": "glucagon-like peptide 1-(7-36) amide", "ligandContext": "", "endogenous": true, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "9.2", "affinityParameter": "pKi", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 2880, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 1138, "ligandName": "exendin-(9-39)", "ligandContext": "", "endogenous": false, "type": "Antagonist", "action": "Antagonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "8.1", "affinityParameter": "pKi", "originalAffinity": "7.94x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 3585, "pmid": 15528268, "type": "Journal", "title": "Mol Endocrinol", "year": 2005, "volume": "19", "issue": "3", "pages": "812-23", "articleTitle": "Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.", "authors": "Jorgensen R, Martini L, Schwartz TW, Elling CE" } ] }, { "interactionId": 8912, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 3730, "ligandName": "exendin-3", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "", "affinityParameter": "", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 14774, "pmid": 1704369, "type": "Journal", "title": "J Biol Chem", "year": 1991, "volume": "266", "issue": "5", "pages": "2897-902", "articleTitle": "Exendin-3, a novel peptide from Heloderma horridum venom, interacts with vasoactive intestinal peptide receptors and a newly described receptor on dispersed acini from guinea pig pancreas. Description of exendin-3(9-39) amide, a specific exendin receptor antagonist.", "authors": "Raufman JP, Singh L, Eng J" } ] }, { "interactionId": 8880, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 3544, "ligandName": "glucagon-like peptide 1-(7-37)", "ligandContext": "", "endogenous": true, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "", "affinityParameter": "", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 14784, "pmid": 8404634, "type": "Journal", "title": "Endocrinology", "year": 1993, "volume": "133", "issue": "4", "pages": "1907-10", "articleTitle": "Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor.", "authors": "Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, Boyd AE" } ] }, { "interactionId": 79371, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 1135, "ligandName": "exendin-4", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "9.2", "affinityParameter": "pIC50", "originalAffinity": "6.6x10-10", "originalAffinityType": "IC50", "originalAffinityRelation": "=", "assayDescription": "Displacement of GLP-1 from hGLP-1 receptor expressed in CHOK1 cells by exendin-4", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 24219, "pmid": 18412318, "type": "Journal", "title": "J Med Chem", "year": 2008, "volume": "51", "issue": "9", "pages": "2758-65", "articleTitle": "Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.", "authors": "Miranda LP, Winters KA, Gegg CV, Patel A, Aral J, Long J, Zhang J, Diamond S, Guido M, Stanislaus S et al.", "pubStatus": "" } ] }, { "interactionId": 80046, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 7585, "ligandName": "BETP", "ligandContext": "", "endogenous": false, "type": "Allosteric modulator", "action": "Positive", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "9.9", "affinityParameter": "pEC50", "originalAffinity": "", "originalAffinityType": "", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 24937, "pmid": 24997604, "type": "Journal", "title": "Nat Chem Biol", "year": 2014, "volume": "10", "issue": "8", "pages": "629-31", "articleTitle": "A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification.", "authors": "Nolte WM, Fortin JP, Stevens BD, Aspnes GE, Griffith DA, Hoth LR, Ruggeri RB, Mathiowetz AM, Limberakis C, Hepworth D et al." } ] }, { "interactionId": 84708, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 9724, "ligandName": "semaglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "9.4", "affinityParameter": "pIC50", "originalAffinity": "3.8x10-10", "originalAffinityType": "IC50", "originalAffinityRelation": "=", "assayDescription": "Membrane radioligand displacement assay (125I-GLP-1 as tracer) performed in the absence of human serum albumin.", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": true, "refs": [ { "referenceId": 33890, "pmid": 26308095, "type": "Journal", "title": "J Med Chem", "year": 2015, "volume": "58", "issue": "18", "pages": "7370-80", "articleTitle": "Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.", "authors": "Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB et al.", "pubStatus": "" } ] }, { "interactionId": 84709, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": true, "targetBindingSite": "", "ligandId": 9724, "ligandName": "semaglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "11.2", "affinityParameter": "pEC50", "originalAffinity": "6.2x10-12", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "In vitro potency assessed in BHK cells expressing the human GLP-1R and a luciferase reporter system.", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 33890, "pmid": 26308095, "type": "Journal", "title": "J Med Chem", "year": 2015, "volume": "58", "issue": "18", "pages": "7370-80", "articleTitle": "Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.", "authors": "Lau J, Bloch P, Schäffer L, Pettersson I, Spetzler J, Kofoed J, Madsen K, Knudsen LB, McGuire J, Steensgaard DB et al.", "pubStatus": "" } ] }, { "interactionId": 88903, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 12175, "ligandName": "orforglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Partial agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.5", "affinityParameter": "pKi", "originalAffinity": "3.22x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "Quantified by [125I]GLP-1(7-36) competition binding using GLP-1R expressing cell membranes", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 44102, "pmid": 33177239, "type": "Journal", "title": "Proc Natl Acad Sci U S A", "year": 2020, "volume": "117", "issue": "47", "pages": "29959-29967", "articleTitle": "Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.", "authors": "Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 90702, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13315, "ligandName": "taspoglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.2", "affinityParameter": "pEC50", "originalAffinity": "6x10-11", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "stimulating cAMP production", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 47396, "pmid": 20382695, "type": "Journal", "title": "Endocrinology", "year": 2010, "volume": "151", "issue": "6", "pages": "2474-82", "articleTitle": "Taspoglutide, an analog of human glucagon-like Peptide-1 with enhanced stability and in vivo potency.", "authors": "Sebokova E, Christ AD, Wang H, Sewing S, Dong JZ, Taylor J, Cawthorne MA, Culler MD", "pubStatus": "", "doi": "" } ] }, { "interactionId": 90703, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13316, "ligandName": "maridebart cafraglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.6", "affinityParameter": "pEC50", "originalAffinity": "2.44x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "In vitro potency in GLP-1R recombinant cells", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 47398, "pmid": 38316982, "type": "Journal", "title": "Nat Metab", "year": 2024, "volume": "6", "issue": "2", "pages": "290-303", "articleTitle": "A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.", "authors": "Véniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 90798, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13383, "ligandName": "survodutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "9.5", "affinityParameter": "pEC50", "originalAffinity": "3.3x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined using a cAMP assay in CHO-K1 cells expressing hGLPIR", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 47623, "pmid": 36356832, "type": "Journal", "title": "Mol Metab", "year": 2022, "volume": "66", "issue": "", "pages": "101633", "articleTitle": "BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.", "authors": "Zimmermann T, Thomas L, Baader-Pagler T, Haebel P, Simon E, Reindl W, Bajrami B, Rist W, Uphues I, Drucker DJ et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91155, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13769, "ligandName": "retatrutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Non-selective", "concentrationRange": "", "affinity": "9.1", "affinityParameter": "pEC50", "originalAffinity": "7.8x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined in a cAMP assay", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 48693, "pmid": 35985340, "type": "Journal", "title": "Cell Metab", "year": 2022, "volume": "34", "issue": "9", "pages": "1234-1247.e9", "articleTitle": "LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.", "authors": "Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91156, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13769, "ligandName": "retatrutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Non-selective", "concentrationRange": "", "affinity": "8.1", "affinityParameter": "pKi", "originalAffinity": "7.2x10-9", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 48693, "pmid": 35985340, "type": "Journal", "title": "Cell Metab", "year": 2022, "volume": "34", "issue": "9", "pages": "1234-1247.e9", "articleTitle": "LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.", "authors": "Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O'Farrell LS, Briere DA, Sloop KW, Thomas MK et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91245, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13834, "ligandName": "compound 73 [PMID: 40167442]", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.3", "affinityParameter": "pEC50", "originalAffinity": "4.8x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Agonist potency determined in a cAMP accumulation assay", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 48981, "pmid": 40167442, "type": "Journal", "title": "J Med Chem", "year": 2025, "volume": "68", "issue": "7", "pages": "7662-7692", "articleTitle": "Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.", "authors": "Miao L, Lou J, Xu S, Zhang J, Zhong Y, Wang G, Li Y, Lei S, Shao S, Wang J et al." } ] }, { "interactionId": 91246, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13834, "ligandName": "compound 73 [PMID: 40167442]", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "6.1", "affinityParameter": "pEC50", "originalAffinity": "8.637x10-7", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined in a β-arrestin2 recruitment assay", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 48981, "pmid": 40167442, "type": "Journal", "title": "J Med Chem", "year": 2025, "volume": "68", "issue": "7", "pages": "7662-7692", "articleTitle": "Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.", "authors": "Miao L, Lou J, Xu S, Zhang J, Zhong Y, Wang G, Li Y, Lei S, Shao S, Wang J et al." } ] }, { "interactionId": 91300, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13870, "ligandName": "DA-302168S", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.9", "affinityParameter": "pEC50", "originalAffinity": "1.32x10-9", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined using a luciferase assay in HEK293 cells expressing hGLP-1R", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49077, "pmid": 40257122, "type": "Journal", "title": "J Med Chem", "year": 2025, "volume": "68", "issue": "9", "pages": "9555-9583", "articleTitle": "Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist.", "authors": "Dong G, Ye Q, Li W, Zhang S, Yang Z, Zhang R, Deng T, Li H, Zhang Y, Zhang X et al." } ] }, { "interactionId": 91301, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 12064, "ligandName": "danuglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.6", "affinityParameter": "pEC50", "originalAffinity": "2.35x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined in a luciferase assay in HEK293 cells expressing hGLP-1R", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49077, "pmid": 40257122, "type": "Journal", "title": "J Med Chem", "year": 2025, "volume": "68", "issue": "9", "pages": "9555-9583", "articleTitle": "Discovery and Evaluation of DA-302168S as an Efficacious Oral Small-Molecule Glucagon-Like Peptide-1 Receptor Agonist.", "authors": "Dong G, Ye Q, Li W, Zhang S, Yang Z, Zhang R, Deng T, Li H, Zhang Y, Zhang X et al." } ] }, { "interactionId": 91371, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13924, "ligandName": "mazdutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.6", "affinityParameter": "pKi", "originalAffinity": "2.3x10-8", "originalAffinityType": "Ki", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49224, "type": "Patent", "year": 2018, "articleTitle": "Glucagon and GLP-1 co-agonist compounds", "authors": "Mezo AR, Chen Y, Valenzuela FA, Qu H", "url": "https://patents.google.com/patent/US9938335B2", "patentNumber": "US9938335B2", "priorityDate": "2016-06-16Z", "publicationDate": "2018-04-10Z", "assignee": "Eli Lilly and Co" } ] }, { "interactionId": 91372, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13924, "ligandName": "mazdutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.6", "affinityParameter": "pEC50", "originalAffinity": "2.39x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49224, "type": "Patent", "year": 2018, "articleTitle": "Glucagon and GLP-1 co-agonist compounds", "authors": "Mezo AR, Chen Y, Valenzuela FA, Qu H", "url": "https://patents.google.com/patent/US9938335B2", "patentNumber": "US9938335B2", "priorityDate": "2016-06-16Z", "publicationDate": "2018-04-10Z", "assignee": "Eli Lilly and Co" } ] }, { "interactionId": 91432, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 13970, "ligandName": "ecnoglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.7", "affinityParameter": "pEC50", "originalAffinity": "1.8x10-11", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Measuring agonist-induced intracellular cAMP accumulation", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49351, "pmid": 37364710, "type": "Journal", "title": "Mol Metab", "year": 2023, "volume": "75", "issue": "", "pages": "101762", "articleTitle": "Discovery of ecnoglutide - A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog.", "authors": "Guo W, Xu Z, Zou H, Li F, Li Y, Feng J, Zhu Z, Zheng Q, Zhu R, Wang B et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91635, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14092, "ligandName": "lotiglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "9.0", "affinityParameter": "pEC50", "originalAffinity": "9.6x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 49898, "type": "Patent", "year": 2020, "articleTitle": "GLP-1 receptor agonists and uses thereof", "authors": "Aspnes GE, Bagley SW, Curto JM, Edmonds DJ, Flanagan ME, Futasugi K, Griffith DA, Huard K, Lian Y, Limberakis C et al.", "url": "https://patents.google.com/patent/US10676465B2", "patentNumber": "US10676465B2", "priorityDate": "2019-08-08Z", "publicationDate": "2020-06-09Z", "assignee": "Pfizer Corp SRL" } ] }, { "interactionId": 91747, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14175, "ligandName": "naperiglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.9", "affinityParameter": "pEC50", "originalAffinity": "1.14x10-9", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "cAMP response in HEK293 cells exoressing hGLP-1 receptor", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 50219, "type": "Patent", "year": 2020, "articleTitle": "Glucagon-like peptide 1 receptor agonists", "authors": "Coates DA, Fields T, Ho JD, Qu F", "url": "https://patents.google.com/patent/WO2020263695A1", "patentNumber": "WO2020263695A1", "priorityDate": "2020-06-19Z", "publicationDate": "2020-12-30Z", "assignee": "Eli Lilly And Company" } ] }, { "interactionId": 91911, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14279, "ligandName": "dapiglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "9.7", "affinityParameter": "pEC50", "originalAffinity": "1.9x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined in a cAMP acummulation assay in HEK293 cells stably expressing hGLP-1R", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 50725, "pmid": 34705281, "type": "Journal", "title": "JPEN J Parenter Enteral Nutr", "year": 2022, "volume": "46", "issue": "5", "pages": "1107-1118", "articleTitle": "Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel.", "authors": "Reiner J, Berlin P, Held J, Thiery J, Skarbaliene J, Griffin J, Russell W, Eriksson PO, Berner-Hansen M, Ehlers L et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91912, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 1133, "ligandName": "liraglutide", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.5", "affinityParameter": "pEC50", "originalAffinity": "3x10-11", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determined in a cAMP acummulation assay in HEK293 cells stably expressing hGLP-1R", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 50725, "pmid": 34705281, "type": "Journal", "title": "JPEN J Parenter Enteral Nutr", "year": 2022, "volume": "46", "issue": "5", "pages": "1107-1118", "articleTitle": "Dapiglutide, a novel dual GLP-1 and GLP-2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel.", "authors": "Reiner J, Berlin P, Held J, Thiery J, Skarbaliene J, Griffin J, Russell W, Eriksson PO, Berner-Hansen M, Ehlers L et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91941, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14316, "ligandName": "glutazumab", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Binding", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.3", "affinityParameter": "pKd", "originalAffinity": "5.09x10-9", "originalAffinityType": "Kd", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 50890, "pmid": 29355505, "type": "Journal", "title": "Biochem Pharmacol", "year": 2018, "volume": "150", "issue": "", "pages": "46-53", "articleTitle": "Glutazumab, a novel long-lasting GLP-1/anti-GLP-1R antibody fusion protein, exerts anti-diabetic effects through targeting dual receptor binding sites.", "authors": "Li C, Yang M, Wang X, Zhang H, Yao C, Sun S, Liu Q, Pan H, Liu S, Huan Y et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 91995, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14358, "ligandName": "conveglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Selective", "concentrationRange": "", "affinity": "10.5", "affinityParameter": "pEC50", "originalAffinity": "3x10-11", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 51046, "pmid": 39140772, "type": "Journal", "title": "J Med Chem", "year": 2024, "volume": "67", "issue": "17", "pages": "14820-14839", "articleTitle": "Design and Evaluation of 3-Phenyloxetane Derivative Agonists of the Glucagon-Like Peptide-1 Receptor.", "authors": "Zhang Z, Pan H, Guo L, Cai C, Chen T, Zhang Z, Yang X, Zheng H, Jiang C, Wang Z et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 92014, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14376, "ligandName": "elecoglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "8.6", "affinityParameter": "pIC50", "originalAffinity": "2.4x10-9", "originalAffinityType": "IC50", "originalAffinityRelation": "=", "assayDescription": "", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 51081, "pmid": 39495140, "type": "Journal", "title": "Diabetes Obes Metab", "year": 2025, "volume": "27", "issue": "2", "pages": "551-562", "articleTitle": "Non-clinical and first-in-human characterization of ECC5004/AZD5004, a novel once-daily, oral small-molecule GLP-1 receptor agonist.", "authors": "Haggag AZ, Xu J, Butcher L, Pagnussat S, Davies G, Lundqvist S, Wang W, Van Zuydam N, Nelander K, Jha A et al.", "pubStatus": "", "doi": "" } ] }, { "interactionId": 92080, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14436, "ligandName": "aleniglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Full agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "10.0", "affinityParameter": "pEC50", "originalAffinity": "1x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "<", "assayDescription": "Determined in a cAMP accumulation assay using a HEK293/CRE-Luc cell line stably expressing the hGLP-1 receptor", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 51297, "type": "Patent", "year": 2023, "articleTitle": "Heterocyclic glp-1 agonists", "authors": "Meng Q, Lin X, Zhang H, Xing W, Lei H, Jennings A", "url": "https://patents.google.com/patent/WO2023016546A1", "patentNumber": "WO2023016546A1", "priorityDate": "2022-08-12Z", "publicationDate": "2023-02-16Z", "assignee": "Gasherbrum Bio Inc" } ] }, { "interactionId": 92081, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14437, "ligandName": "tifeglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "7.3", "affinityParameter": "pEC50", "originalAffinity": "5x10-8", "originalAffinityType": "EC50", "originalAffinityRelation": "<", "assayDescription": "Determined in a GLP-1R cAMP accumulation assay in CHO cells", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 51299, "type": "Patent", "year": 2025, "articleTitle": "Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use", "authors": "Du X", "url": "https://patents.google.com/patent/US20250154137A1", "patentNumber": "US20250154137A1", "priorityDate": "2025-01-14Z", "publicationDate": "2025-05-15Z", "assignee": "Carmot Therapeutics Inc" } ] }, { "interactionId": 92082, "targetId": 249, "targetName": "GLP-1 receptor", "ligandAsTargetId": 0, "targetSpecies": "Human", "primaryTarget": false, "targetBindingSite": "", "ligandId": 14438, "ligandName": "safiglipron", "ligandContext": "", "endogenous": false, "type": "Agonist", "action": "Agonist", "actionComment": "", "selectivity": "Not Determined", "concentrationRange": "", "affinity": "9.1", "affinityParameter": "pEC50", "originalAffinity": "7.4x10-10", "originalAffinityType": "EC50", "originalAffinityRelation": "=", "assayDescription": "Determine in a cAMP elevation assay in CHO-K1 cells stably expressing a hGLP-1 receptor", "assayConditions": "", "useDependent": false, "voltageDependent": false, "voltage": "", "physiologicalVoltage": false, "conciseView": false, "refs": [ { "referenceId": 51301, "type": "Patent", "year": 2023, "articleTitle": "Fused imidazole derivative, preparation method therefor, and medical use thereof", "authors": "Yang F, Zhang L, Zheng L, He F, Tao W", "url": "https://patents.google.com/patent/US20230322756A1", "patentNumber": "US20230322756A1", "priorityDate": "2021-09-01Z", "publicationDate": "2023-10-12Z", "assignee": "Shanghai Hengrui Pharmaceutical Co Ltd , Jiangsu Hengrui Pharmaceutical Co Ltd" } ] } ]